Maximus, Inc. (NYSE:MMS) Shares Bought by Bank of New York Mellon Corp

Bank of New York Mellon Corp lifted its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 8.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 570,740 shares of the health services provider's stock after purchasing an additional 43,421 shares during the quarter. Bank of New York Mellon Corp owned 1.00% of Maximus worth $42,606,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. State of Alaska Department of Revenue lifted its holdings in Maximus by 5.5% in the 3rd quarter. State of Alaska Department of Revenue now owns 6,987 shares of the health services provider's stock valued at $650,000 after purchasing an additional 365 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its stake in Maximus by 32.8% during the third quarter. Robeco Institutional Asset Management B.V. now owns 17,635 shares of the health services provider's stock worth $1,643,000 after buying an additional 4,354 shares during the period. QRG Capital Management Inc. increased its holdings in Maximus by 31.9% in the 3rd quarter. QRG Capital Management Inc. now owns 4,336 shares of the health services provider's stock valued at $404,000 after purchasing an additional 1,048 shares during the last quarter. Atria Investments Inc purchased a new position in shares of Maximus in the third quarter valued at approximately $244,000. Finally, Covestor Ltd grew its stake in shares of Maximus by 913.0% in the third quarter. Covestor Ltd now owns 1,246 shares of the health services provider's stock worth $116,000 after acquiring an additional 1,123 shares in the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Maximus Stock Down 1.7 %

Maximus stock traded down $1.20 during trading on Monday, reaching $69.98. The stock had a trading volume of 861,044 shares, compared to its average volume of 478,606. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The stock has a market cap of $3.96 billion, a PE ratio of 15.05 and a beta of 0.71. The business has a 50 day moving average price of $72.77 and a 200 day moving average price of $80.14.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.71%. Maximus's dividend payout ratio is currently 25.81%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd. StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

Insider Buying and Selling at Maximus

In other news, Director Raymond B. Ruddy acquired 3,490 shares of the company's stock in a transaction on Thursday, December 12th. The shares were bought at an average price of $71.46 per share, with a total value of $249,395.40. Following the completion of the acquisition, the director now owns 112,520 shares in the company, valued at $8,040,679.20. This trade represents a 3.20 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares of the company's stock, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have purchased 7,008 shares of company stock worth $497,835 over the last three months. Insiders own 1.60% of the company's stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.